Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (DATiC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Cape Town
Sponsor:
Collaborators:
Liverpool School of Tropical Medicine
Uppsala University
University of North Carolina
Information provided by (Responsible Party):
Helen Margaret McIlleron, University of Cape Town
ClinicalTrials.gov Identifier:
NCT01637558
First received: July 2, 2012
Last updated: October 26, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):